Recent Finacing
Recent Raise
Napo Pharmaceuticals develops and commercializes crofelemer-based therapeutics sourced via rainforest partnerships, operating clinical development and global licensing programs for human (Mytesi) and veterinary indications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors